Suven Life Sciences Ltd share price logo

Suven Life Sciences Ltd

NSE: SUVEN

BSE: 530239

Small Cap

Healthcare Sector

₹218.60

+7.00

(+3.31%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Suven Life Sciences Stock Performance

as on April 28, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹214.10
    ₹229.69
    downward going graph

    2.06%

    Downside

    5.07%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹120.12
    ₹299.99
    downward going graph

    45.05%

    Downside

    37.23%

    Upside

    downward going graph

Suven Life Sciences share price movements today

Previous Close
₹211.60
Open
₹214.10
Volume
10.16L
Upper Circuit
₹253.92
Lower Circuit
₹169.28
Day's Low - High
₹214.10 - ₹229.69
52 Week Low - High
₹120.12 - ₹299.99

Suven Life Sciences Historical Returns

1 Month Return
+ 60.67 %
3 Month Return
+ 60.32 %
1 Year Return
+ 58.73 %
3 Year Return
+ 270.25 %
5 Year Return
+ 98.87 %

Suven Life Sciences Fundamentals

as on April 28, 2026 at 4:01 pm IST

Market Cap

₹5,580.33 Cr

Return on Equity (ROE)

-6.33

PE Ratio (TTM)

-17.05

Return on capital employed (ROCE)

-6.3

Industry PE ratio

48.52

Beta (LTM)

1.02

P/B Ratio

3.09

Dividend Yield

0

PEG Ratio

2.92

Quarterly Earnings Growth YOY

160.53

EPS (TTM)

-7.37

Sector

Healthcare

Book Value

5.04

Suven Life Sciences Stock Valuation

as on April 28, 2026 at 4:01 pm IST

Suven Life Sciences in the last 5 years

  • Overview

  • Trends

Lowest (-165.11x)

February 27, 2020

Today (-17.05x)

April 27, 2026

Industry (48.52x)

April 27, 2026

Highest (-6.67x)

March 27, 2023

LowHigh

Today’s Price to Earnings Ratio: -17.05x

Suven Life Sciences Technical Analysis

Track how Suven Life Sciences technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish2
Bullish10
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.16
Bullish
CCI (20)
375.96
Bearish
RSI (14)
59
Neutral
Momentum (10)
1.21
Bullish
ADI (14)
19.34
Neutral
Ultimate Oscillator (7,14,28)
38.36
Neutral

Moving Averages

Name

Value

Action

SMA (20)
218.53
Bullish
EMA (20)
218.63
Bullish
VWMA (20)
218.66
Bullish
SMA (50)
218.53
Bullish
EMA (50)
218.57
Bullish
SMA (200)
219.25
Bearish
EMA (200)
219.07
Bullish
KAMA (200)
218.83
Bullish
DEMA (200)
218.98
Bullish

Suven Life Sciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Suven Life Sciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Suven Life Sciences Ltd image
Suven Life Sciences Ltd
NA5,580.3319.77%0.51-1616
Vijaya Diagnostic Centre Ltd image
Vijaya Diagnostic Centre Ltd
BUY11,442.6315.87%0.65143704
Aspira Pathlab & Diagnostics Ltd image
Aspira Pathlab & Diagnostics Ltd
NA66.1322.98%0.58222
Global Longlife Hospital and Research Ltd image
Global Longlife Hospital and Research Ltd
NA14.82-17.92%0.00-313
Chennai Meenakshi Multispeciality Hospital Ltd image
Chennai Meenakshi Multispeciality Hospital Ltd
NA29.8760.6%0.00-234
See all

Suven Life Sciences Stock’s Investor Sentiment and Interest

Search interest for Suven Life Sciences Ltd Stock has increased by 78% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:78% versus previous 30 day period

Suven Life Sciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
3.8
3.06
2.45
2.39
1.01
2.57
1.61
1.47
1.87
0.92
2.81
Other Income
5.64
12.6
6.07
4.28
4.01
4.04
1.63
1.22
0.6
3.78
2.77
Total Income
9.44
15.66
8.52
6.67
5.01
6.61
3.24
2.69
2.47
4.7
5.58
Expenses
31.81
26.57
48.64
32.67
31.54
54.78
40.82
45.29
52.62
80.69
106.16
Operating Profit
-28.01
-23.51
-46.19
-30.28
-30.53
-52.21
-39.21
-43.82
-50.75
-79.77
-103.35
Operating Profit Margin %
-737.11%
-768.3%
-1885.31%
-1266.95%
-3022.77%
-2031.52%
-2435.4%
-2980.95%
-2713.9%
-8670.65%
-3677.94%
Profit Before Interest, Tax and Depreciation
-22.37
-10.91
-40.13
-26
-26.53
-48.17
-37.58
-42.6
-50.15
-75.99
-100.58
Interest
0.05
0.04
0.04
0.03
0.02
0.02
0.01
-
-
-
-
Depreciation
1.66
1.73
1.6
1.51
1.49
1.46
1.53
1.35
1.37
1.32
1.35
Profit Before Tax
-24.08
-12.68
-41.77
-27.54
-28.04
-49.65
-39.12
-43.95
-51.52
-77.31
-101.93
Tax Paid
-
-
-
-1
-
-
-
-
-
-
-
Profit After Tax
-24.09
-12.68
-41.76
-26.54
-28.04
-49.64
-39.12
-43.94
-51.52
-77.31
-101.92
Total Net profit including share of profit / Loss from associate company
-24.09
-12.68
-41.76
-26.54
-28.04
-49.64
-39.12
-43.94
-51.52
-77.31
-101.92
EPS
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
-3.48
-4.55
Actual EPS
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
-3.48
-4.55
Adjusted EPS
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
-3.48
-4.55
Diluted EPS
-1.1
-0.58
-1.92
-1.22
-1.29
-2.27
-1.79
-2.02
-2.36
-3.48
-4.55

Suven Life Sciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
625.26
285.67
14.41
13.48
11.84
13.54
11.69
6.66
Other Income
23.27
27.25
14.04
7.75
5.32
14.45
28.59
10.9
Total Income
648.53
312.91
28.45
21.23
17.16
27.99
40.28
17.55
Expenses
427.07
300.06
130.2
93.54
134.23
139.42
139.7
172.43
Operating Profit
198.19
-14.39
-115.79
-80.06
-122.39
-125.88
-128.01
-165.77
Operating Profit Margin %
31.7%
-5.04%
-803.54%
-593.92%
-1033.7%
-929.69%
-1095.04%
-2489.04%
Profit Before Interest, Tax and Depreciation
221.46
12.86
-101.75
-72.31
-117.07
-111.44
-99.42
-154.88
Interest
4.63
1.91
0.49
0.82
0.53
0.29
0.16
0.05
Depreciation
21.31
10.79
4.17
4.35
4.39
6.54
6.5
5.82
Profit Before Tax
195.52
0.16
-106.41
-77.48
-121.99
-118.27
-106.08
-160.75
Tax Paid
71.83
24.06
-12.18
-5.32
-
-
-1
-
Profit After Tax
123.69
-23.9
-94.22
-72.15
-122
-118.27
-105.08
-160.75
Total Net profit including share of profit / Loss from associate company
123.69
-23.9
-94.22
-72.15
-122
-118.27
-105.08
-160.75
EPS
9.72
-1.88
-7.4
-5.67
-9.05
-6.63
-4.82
-7.37
Actual EPS
9.72
-1.88
-7.4
-5.67
-9.05
-6.63
-4.82
-7.37
Adjusted EPS
0.45
-0.09
-6.82
-5.22
-8.34
-6.63
-4.82
-7.37
Diluted EPS
9.72
-1.88
-7.4
-5.67
-9.05
-6.63
-4.82
-7.37

Suven Life Sciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
67.5
109.17
69.94
-52.61
-134.57
-96.02
-127.54
-115.98
-115.47
-154.1
Cash Flow from Investing Activities
-38.63
-310.64
-0.61
30.43
146.21
55.85
-22.22
-247.81
94.44
154.95
Cash Flow from Financing Activities
-68.07
-30.39
-52.07
4.54
2.8
34.85
145.69
395.54
-1.06
-0.76
Net Cash Flow
-39.2
-231.86
17.26
-17.66
14.45
-5.33
-4.07
31.75
-22.09
0.09

Suven Life Sciences Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Jul 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
69.57%
69.57%
69.57%
69.57%
70.27%
70.27%
70.27%
70.27%
70.27%
67.43%
67.36%
67.36%
70.15%
DII
0.08%
0.01%
0.12%
1.17%
1.17%
1.05%
1.06%
0.01%
0.02%
3.41%
3.39%
3.39%
4.62%
FII
0%
0.5%
0.54%
0.46%
0.45%
0.34%
0.34%
0.25%
0.59%
0.56%
1.18%
1.07%
0.91%
Public
29.88%
29.93%
29.77%
28.81%
28.12%
28.34%
28.34%
29.47%
29.12%
28.61%
28.07%
28.18%
24.32%
Total Outstanding Shares
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
21,80,73,717
22,72,60,207
22,74,74,207
22,74,74,207
26,37,20,583
Total Shareholders
76,291
80,953
74,003
68,959
66,116
63,975
63,537
64,603
66,159
65,574
64,921
64,381
63,915

Mutual Funds that own Suven Life Sciences Stock

Check out the Mutual Funds with significant holdings in Suven Life Sciences.

Suven Life Sciences Corporate Actions

View detailed summary of the earnings and dividend history of Suven Life Sciences.

  • Suven Life Sciences Ltd Earnings Results

    Suven Life Sciences Ltd’s net profit fell -160.53% since last year same period to ₹-101.92Cr in the Q3 2025-2026. On a quarterly growth basis, Suven Life Sciences Ltd has generated -31.83% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Suven Life Sciences Ltd Dividends February,2019

    In the quarter ending December 2018, Suven Life Sciences Ltd has declared dividend of ₹1.50 per share on 05 Feb 2019 - translating a dividend yield of 0.71%.

    Read More about Dividends

Indices Featuring Suven Life Sciences Stock

Check stock indices that include Suven Life Sciences.

BSE Healthcare

₹44,563.26

-0.26 (▲114.11%)

Insights on Suven Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 2.47 Cr → 5.58 Cr (in ₹), with an average increase of 31.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SUVEN stock has moved up by 60.7%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SUVEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SUVEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 67.36% to 70.15% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 5 quarters, -39.12 Cr → -101.92 Cr (in ₹), with an average decrease of 27.9% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 28.18% to 24.32% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.07% to 0.91% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 2.08% to 1.79% in Mar 2026 quarter

About Suven Life Sciences Ltd

Suven Life Sciences Limited (erstwhile Suven Pharmaceuticals), established in 1989, is in the business of Contract Research and Manufacturing Services (CRAMS), providing process research and rapid response pilots scale 16 manufacture, custom synthesis, process R&D, and contract manufacturing of intermediates, APIs and formulations. It has two international wholly owned subsidiaries and one Indian wholly owned subsidiary. With the aim of expanding its drug discovery portfolio, a remarkable growth of 71% in total sales and a 325% growth in profit after tax (PAT) was registered during 2000-01. In addition, the company also acquired a pilot plant and got its recertification of ISO 9002 during the same year. In 2013-14, Suven granted an exclusive license to Taro Pharmaceuticals to market its product Head Lice Lotion in the US, Canada and Mexico, estimated at US$35million. During FY2014-15, one of its lead clinical candidates SUVN 502 has successfully completed the Phase 1b clinical trial, leading way for the entry into Proof of Concept (PoC) Phase 2a study. Thesaid year also saw the Company issuing and alloting 10, 453, 690 equity shares of Re 1/ each at a premium of Rs190.32 per share by way of QIP issue. In 2018-19, a Scheme of Arrangement for Demerger was initiated between Suven Life Sciences and Suven Pharmaceuticals Limited, resulting in a mirror shareholding of Suven Life Sciences in Suven Pharmaceuticals Limited. Consequently, Suven Pharmaceuticals Ltd., India and Suven Pharma Inc., USA became subsidiary companies of the group. As of 31st March 2019, investments were made to Suven Neurosciences Inc., a wholly owned subsidiary, amounting to Rs. 13, 636 lakh and no investments were made into newly formed Suven Pharma Inc., USA.

Revenue: ₹2.81Cr as on December 2025 (Q3 FY26)
Net Profit: ₹-101.92Cr as on December 2025 (Q3 FY26)
Listing date: 23 Oct, 2003
Chairperson Name: Venkateswarlu Jasti
OrganisationSuven Life Sciences Ltd
HeadquartersHyderabad
IndustryHealthcare
CEOVenkateswarlu Jasti
E-voting on sharesClick here to vote

FAQs

What is Suven Life Sciences share price today?

Suven Life Sciences share price today stands at ₹218.6 as on at the close of the market. Suven Life Sciences share today touched a day high of ₹229.69 and a low of ₹214.1.

What is the 52 week high and 52 week low range for Suven Life Sciences share?

Suven Life Sciences touched a 52 week high of ₹299.99 and a 52 week low of ₹120.12. Suven Life Sciences share price today i.e. is closed at ₹218.6, which is -27.13% down from its 52 week high and 81.98% up from its 52 week low.

What is Suven Life Sciences's market capitalisation today?

Suven Life Sciences market capitalisation is ₹5,580.33 Cr as on .

How to buy Suven Life Sciences shares?

To buy Suven Life Sciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUVEN or Suven Life Sciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Suven Life Sciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Suven Life Sciences trading volume today?

Suven Life Sciences trading volume is 10.16L as on . This means that 10.16L shares of Suven Life Sciences were bought and sold on the stock market during today's trading session.